Urban Höglund
Chief Executive Officer at Adlego Biomedical AB
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Johan Olof Kämpe | M | 68 |
University of Uppsala
| 25 years |
| Niklas Dahl | M | - |
University of Uppsala
| 24 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Annika Margareta Grahn-Westin | F | - |
Visionar Preclinical AB
 Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | 11 years |
| Mats Bo Johan Nilsson Bernitz | M | 54 |
University of Uppsala
| 3 years |
| Eric Gunnar Daniel Persson | M | 52 |
University of Uppsala
| 4 years |
| Gunilla Lundmark | F | 61 |
University of Uppsala
| 2 years |
| Björn Henriksson | M | - |
University of Uppsala
| 13 years |
| Michael Holmberg | M | 51 |
University of Uppsala
| 5 years |
| Claes Johan Ingemar Nycander | M | 61 |
University of Uppsala
| 2 years |
| Henrik Berg | M | - |
University of Uppsala
| 4 years |
| Charlotta Göransson | M | 52 |
University of Uppsala
| 3 years |
| Louise Nicolin | F | 51 |
University of Uppsala
| 1 years |
| Peter Gönczi | M | 49 |
University of Uppsala
| 4 years |
| Markus Kitunen | M | - |
University of Uppsala
| 5 years |
| Annica Bresky | F | 49 |
University of Uppsala
| 6 years |
| Olof Stranding | M | - |
University of Uppsala
| 4 years |
| Charlotte Kristin Lindberg | F | 48 |
University of Uppsala
| 3 years |
| Carl Magnus Nikolaus Brandberg | M | 44 |
University of Uppsala
| 5 years |
| Torsten Brandberg | M | 44 |
University of Uppsala
| 6 years |
| Therese Lundstedt | F | 43 |
University of Uppsala
| 4 years |
| Daniel Althoff | M | - |
University of Uppsala
| 4 years |
| Mattias Lilja | M | 52 |
University of Uppsala
| 4 years |
| Karin Kronhoffer | F | - |
University of Uppsala
| 5 years |
| Stina Wallmark | F | - |
University of Uppsala
| 7 years |
| Karin Göransson | F | 45 |
University of Uppsala
| 5 years |
| Jonas Lejontand | M | 46 |
University of Uppsala
| 4 years |
| Kajsa Gustafsson | F | - |
University of Uppsala
| 4 years |
| Malin Lundgren | F | 46 |
University of Uppsala
| 4 years |
| Fredrik Ljungblad | M | - |
University of Uppsala
| 1 years |
| Karl Svensson | M | 47 |
University of Uppsala
| 2 years |
| Qing Hai Zhao | M | 64 |
University of Uppsala
| 3 years |
| Pontus Englund | M | - |
University of Uppsala
| 1 years |
| Viktor Berglind | M | - |
University of Uppsala
| 4 years |
| Jenny Lindstrom | F | 49 |
University of Uppsala
| 1 years |
| Hildur Hadenius | M | 49 |
University of Uppsala
| 3 years |
| Therese Nyrén | F | - |
University of Uppsala
| 3 years |
| Magnus Sjöcrona | M | - |
University of Uppsala
| 6 years |
| Mikael Boman | M | - |
University of Uppsala
| 5 years |
| Joakim Karlsson | M | - |
University of Uppsala
| 4 years |
| Hans Ehrsson | M | - |
University of Uppsala
| 17 years |
| Jonas Karl Hansson | M | 50 |
University of Uppsala
| 5 years |
| Paola Longati | M | - |
University of Uppsala
| 1 years |
| Jan-Anders Christer Mellberg | M | 76 |
Visionar Preclinical AB
Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | - |
| Girish Ganesan | M | - |
University of Uppsala
| 4 years |
| Nils-Peter Kristensen | M | 61 |
University of Uppsala
| 1 years |
| Magnus Kreuger | M | 68 |
University of Uppsala
| 2 years |
| Erik Hultgård | M | - |
University of Uppsala
| 1 years |
| Johan Bevemyr | M | - |
University of Uppsala
| 3 years |
| Carl Johan Olof Merner | M | 49 |
University of Uppsala
| 2 years |
| Martin Aparicio | M | - |
University of Uppsala
| 1 years |
| Lars Gunnar Lannfelt | M | 75 |
University of Uppsala
| - |
| Ulrich Heinle | M | - |
University of Uppsala
| 3 years |
| Mats Gullberg | M | 53 |
University of Uppsala
| 3 years |
| Jonas Sven Peter Jarvius | M | 53 |
University of Uppsala
| 1 years |
| Mats Lennart Larsson | M | 62 |
University of Uppsala
| 3 years |
| Anders Rickard Gåhlin | M | 56 |
University of Uppsala
| 3 years |
| Inger Birgitta Fogelberg | F | - |
Visionar Preclinical AB
Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | 11 years |
| Erik Ekman | M | 55 |
University of Uppsala
| 3 years |
| Gustaf Peter Torgny Karling | M | 52 |
University of Uppsala
| 5 years |
| Johan Pejnefors | M | - |
University of Uppsala
| 3 years |
| Georgi Martin Ganev | M | 48 |
University of Uppsala
| 4 years |
| Carl Gustav Fritjofsson | M | - |
University of Uppsala
| 5 years |
| Fredrik Nordh | M | 50 |
University of Uppsala
| 1 years |
| Curt Stefan Carlsson | M | 54 |
University of Uppsala
| 1 years |
| Caroline Pérez | F | 47 |
University of Uppsala
| 1 years |
| Mikael Johansson | M | 47 |
University of Uppsala
| 4 years |
| Lars Olof Gustav Wänstrand | M | 53 |
University of Uppsala
| 3 years |
| Sten-Magnus Aquilonius | M | 85 |
University of Uppsala
| 10 years |
| Peter Nygren | M | 66 |
University of Uppsala
| 2 years |
| John Sjögren | M | - |
University of Uppsala
| 26 years |
| Philippe Nakache | M | - |
University of Uppsala
| 1 years |
| Maria Långberg | F | 54 |
University of Uppsala
| 4 years |
| Jonas Rolf Nordlander | M | 51 |
University of Uppsala
| 5 years |
| Alexander Kempe | M | - |
University of Uppsala
| 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Sweden | 74 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Urban Höglund
- Personal Network
